Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
Health Care – BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Headquarters
- United States
- Employees
- 600
- Market Cap
- $2.0B
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
SentiSense also tracks daily options readings for Recursion Pharmaceuticals, Inc. Class A Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Recursion Pharmaceuticals, Inc. Class A Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.